Clinical Trial Update: A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety, tolerability, and immune responses of an investigational monovalent chimpanzee adenoviral vectored Marburg viru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marburg Virus Disease

Drugs mentioned

• Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine (Monovalent chimpanzee adenoviral-vectored Marburg virus vaccine)

Snippet

Sponsor: Albert B. Sabin Vaccine Institute | Conditions: Marburg Virus Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING